In addition to the effects on cell cycle and apoptosis, almost thirty transcriptional regulators were significantly downregulated (such as EZH2) or upregulated (such as EHF) specifically in the combination group (Table S3B), suggesting combined BRAF and BET inhibition broadly shifts the transcriptional landscape of melanoma cells. The gene discussed is EHF; the disease is melanoma.